(Q50924283)

English

Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women.

scientific article published in October 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

author name string

Ross D

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

Cooper AJ

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

Pryse-Davies J

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

Bergeron C

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

Collins WP

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

Whitehead MI

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

177

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

937-941

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

The effects of oestrogens and progestogens on the postmenopausal endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Transdermal administration of oestrogen/progestagen hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Biliary excretion and intestinal metabolism of progesterone and estrogens in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Absorption and metabolism of oral progesterone.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Absorption and metabolism of oral progesterone when administered twice daily**Supported by a grant from Laboratoires Besins Iscovesco, Paris, France

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Bioavailability of oral micronized progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Experience with a 'physiological' steroid replacement regimen for the establishment of a receptive endometrium in women with premature ovarian failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Transfer of cryopreserved-thawed embryos: the natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

Effects of dydrogesterone on the oestrogenized postmenopausal endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative bioavailability of orally and vaginally administered progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2897%2970297-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9378(97)70297-7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9369848

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50924283&oldid=2138762036"